menu
    • menu
    [{"orgOrder":0,"company":"Verisfield UK Ltd. Greek Branch","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"GREECE","productType":"Miscellaneous","year":"2014","type":"Inapplicable","leadProduct":"Metronidazole Benzoate","moa":"antiprotozoal substances (metronidazole type)","graph1":"Infections and Infectious Diseases","graph2":"Phase I","graph3":"Verisfield UK Ltd. Greek Branch","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Verisfield UK Ltd. Greek Branch \/ Undisclosed","highestDevelopmentStatusID":"6","companyTruncated":"Verisfield UK Ltd. Greek Branch \/ Undisclosed"},{"orgOrder":0,"company":"Tillotts Pharma AG","sponsor":"Swiss Commission for Technology and Innovation | University of Basel | University Hospital, Basel | SocraTec R&D GmbH","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"SWITZERLAND","productType":"Miscellaneous","year":"2016","type":"Inapplicable","leadProduct":"Metronidazole Benzoate","moa":"antiprotozoal substances (metronidazole type)","graph1":"Undisclosed","graph2":"Phase I","graph3":"Tillotts Pharma AG","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Capsule, Enteric Coated","sponsorNew":"Tillotts Pharma AG \/ Swiss Commission for Technology and Innovation | University of Basel | University Hospital, Basel | SocraTec R&D GmbH","highestDevelopmentStatusID":"6","companyTruncated":"Tillotts Pharma AG \/ Swiss Commission for Technology and Innovation | University of Basel | University Hospital, Basel | SocraTec R&D GmbH"}]

    Find Clinical Drug Pipeline Developments & Deals for Metronidazole Benzoate

    Menu

    Metronidazole Benzoate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Tillotts Pharma AG

                            Switzerland arrow
                            COMPAMED
                            Not Confirmed

                            Tillotts Pharma AG

                            Switzerland arrow
                            COMPAMED
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Metronidazole Benzoate

                            Therapeutic Area : Undisclosed

                            Study Phase : Phase I

                            Sponsor : Swiss Commission for Technology and Innovation | University of Basel | University Hospital, Basel | SocraTec R&D GmbH

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Pharmaco-Scintigraphic Study to Evaluate the Release Profile of Metronidazole Benzoate Capsules

                            Details : Metronidazole Benzoate is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            September 22, 2016

                            Lead Product(s) : Metronidazole Benzoate

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Phase I

                            Sponsor : Swiss Commission for Technology and Innovation | University of Basel | University Hospital, Basel | SocraTec R&D GmbH

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Verisfield UK Ltd. Greek Branch

                            Country arrow
                            COMPAMED
                            Not Confirmed

                            Verisfield UK Ltd. Greek Branch

                            Country arrow
                            COMPAMED
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Metronidazole Benzoate

                            Therapeutic Area : Infections and Infectious Diseases

                            Study Phase : Phase I

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Study to Determine the Equivalence of Three Products Containing Metronidazole Benzoate.

                            Details : Metronidazole Benzoate is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Bacterial Infections.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            May 23, 2014

                            Lead Product(s) : Metronidazole Benzoate

                            Therapeutic Area : Infections and Infectious Diseases

                            Highest Development Status : Phase I

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth